Pancreatic cancer survival extended by over a year with chemotherapy regimen
4 Jun 2018
Pancreatic cancer survival extended by over a year with chemotherapy regimen
New pathways in pancreatic cancer
BLU-285 for advanced systemic mastocytosis
The reality of pancreatic cancer
Precision Panc, a platform for pancreatic cancer
The promise of immunotherapy for elderly patients
Delivering complex care in low resource settings
ESMO 2017 highlights on managing difficult to treat cancers
ESMO 2017 roundup with Dr Bishal Gyawali (1/2)
Problems with survivorship care in Europe
Underprovision and inequality of specialised cancer care
Editor's Choice for August 2017